Dorothee Oberdhan

Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease

Wendy E. Boertien, Esther Meijer, Paul E. de Jong et al. · Kidney International · 2013 · 91 citations · Full text

Medicine, Nephrology, Pharmacotherapy +15

Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function

Wendy E. Boertien, Esther Meijer, Paul E. de Jong et al. · American Journal of Kidney Diseases · 2015 · 79 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions

Pei‐Jung Lin, Brittany D’Cruz, Ashley A. Leech et al. · PharmacoEconomics · 2019 · 65 citations · Full text

Medicine, Geriatric Medicine, Cost-effectiveness Analysis +16

Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology–Polycystic Kidney Disease (SONG-PKD) Consensus Workshop

Yeoungjee Cho, Allison Tong, Jonathan C. Craig et al. · American Journal of Kidney Diseases · 2020 · 53 citations · Full text

Medicine, Nephrology, Pediatrics +11

Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument

Dorothee Oberdhan, Jason C. Cole, Holly B. Krasa et al. · American Journal of Kidney Diseases · 2017 · 50 citations · Full text

Medicine, Internal Medicine, Nephrology +16